• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    8.87 Up 0.01(0.11%) May 22, 4:00PM EDT
    |After Hours : 8.87 0.00 (0.00%) May 22, 4:25PM EDT
    Add to Portfolio
    Prev Close:8.86
    Open:8.84
    Bid:8.10 x 300
    Ask:N/A
    1y Target Est:11.04
    Beta:1.37
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:8.81 - 8.99
    52wk Range:3.92 - 9.95
    Volume:1,509,092
    Avg Vol (3m):4,243,960
    Market Cap:2.38B
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXUp 0.11%2.38B
    MRKDown 1.20%167.76B
    NVSDown 0.90%251.35B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):71.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.42
    Quarterly EPS Est (Jun-15) :-0.09
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback